Paper40108720
The needed daily dose of colchicine in patients with Familial Mediterranean Fever may be higher in women: a study on behalf of the JIR cohort.
Di Cola I and 17 others. Arthritis Res Ther, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. The needed daily dose of colchicine in patients with Familial Mediterranean Fever may be higher in women: a study on behalf of the JIR cohort. Papers, record 40108720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40108720
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The needed daily dose of colchicine in patients with Familial Mediterranean Fever may be higher in women: a study on behalf of the JIR cohort.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colchicine | Major topic |
| Familial Mediterranean Fever | Major topic |
| Humans | |
| Female | |
| Adult | |
| Retrospective Studies | |
| Middle Aged | |
| Male | |
| Cohort Studies | |
| Dose-Response Relationship, Drug | |
| Young Adult | |
| Sex Factors | |
| Body Weight |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4636899 | Colchicine for familial Mediterranean fever. | N Engl J Med | 1972 | https://conductscience.org/library/papers/4636899 | PubMed |
| 2 | 3515182 | Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. | N Engl J Med | 1986 | https://conductscience.org/library/papers/3515182 | PubMed |
| 3 | 37298536 | An Update on Familial Mediterranean Fever. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298536 | PubMed |
| 4 | 9336425 | Criteria for the diagnosis of familial Mediterranean fever. | Arthritis Rheum | 1997 | https://conductscience.org/library/papers/9336425 | PubMed |
| 5 | 4606353 | Colchicine therapy for familial mediterranean fever. A double-blind trial. | N Engl J Med | 1974 | https://conductscience.org/library/papers/4606353 | PubMed |
| 6 | 26802180 | EULAR recommendations for the management of familial Mediterranean fever. | Ann Rheum Dis | 2016 | https://conductscience.org/library/papers/26802180 | PubMed |
| 7 | 33910693 | [Familial Mediterranean fever in 2020]. | Nephrol Ther | 2021 | https://conductscience.org/library/papers/33910693 | PubMed |
| 8 | 36223753 | Steroid hormone catabolites activate the pyrin inflammasome through a non-canonical mechanism. | Cell Rep | 2022 | https://conductscience.org/library/papers/36223753 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42399078 | Beyond genotype: clustering analysis highlights clinical heterogeneity in paediatric familial Mediterranean fever. | RMD Open | 2026 | https://conductscience.org/library/papers/42399078 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MEFV | 4210 | PubTator's text mining | https://conductscience.org/library/genes/4210 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40108720
GET https://conductscience.org/api/papers/v1/40108720/authors